Delivery Order SPE2DR25D1201-SPE2DR26FAKDV
- Not listed
- The Defense Logistics Agency awarded a $19,491.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on December 9, 2025, with completion targeted for December 31, 2025. This non-set-aside competitive award represents a single delivery order supporting federal medical procurement needs, with performance based in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector medication. The award was made on November 4, 2025, with an ultimate completion date of November 26, 2025, under a firm fixed-price delivery order contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive...
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 16, 2025, with completion targeted for January 8, 2026. This non-competitive delivery order represents a firm fixed-price transaction under the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Benlysta 200 mg/ml auto-injector pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of January 5, 2026, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, leveraging its...
- The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 18, 2025, with completion scheduled by December 10, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a prescription biologic medication used primarily in the treatment of systemic lupus erythematosus,...
- The Defense Logistics Agency awarded a $24,661.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on September 18, 2025, with an ultimate completion date of October 9, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively procured...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 17, 2025. This is a firm fixed-price delivery order with a completion date of December 9, 2025, with no set-aside designation applied. The award represents a competitive procurement under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's established capability as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,745.98 on December 8, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This firm fixed-price, competitively awarded delivery order is scheduled for completion by December 30, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award is unset-aside and represents a child contract under a larger indefinite delivery vehicle. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This firm fixed-price delivery order, valued at $12,330.68, is scheduled for completion by November 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Benlysta 200 mg/ml auto-injector pharmaceutical product. This firm fixed-price delivery order, valued at $6,165.36, is scheduled for completion by November 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under an existing contract vehicle, demonstrating the contractor's...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKDVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on December 17, 2025. This firm fixed-price delivery order is scheduled for completion by January 9, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded without set-aside restrictions, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement standards. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies critical medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 12/16/25 |